Cardiogenic shock is defined as a systolic blood pressure under 90 mmHg and cardiac index under 2.2 L/m/m2 with a pulmonary capillary wedge pressure over 18 mmHg, caused by impaired cardiac function and inadequate tissue perfusion. Signs include cool skin, tachypnea, hypotension, and altered mental status. Treatment goals are airway stability and improving myocardial pump function through vasoactive drugs, intra-aortic balloon pumps, and coronary reperfusion if possible. Hemodynamic monitoring with a Swan-Ganz catheter can help differentiate shock types and guide treatment, though catheters may increase mortality risk due to selection bias.
Cardiogenic shock is defined as a systolic blood pressure under 90 mmHg and cardiac index under 2.2 L/m/m2 with a pulmonary capillary wedge pressure over 18 mmHg, caused by impaired cardiac function and inadequate tissue perfusion. Signs include cool skin, tachypnea, hypotension, and altered mental status. Treatment goals are airway stability and improving myocardial pump function through vasoactive drugs, intra-aortic balloon pumps, and coronary reperfusion if possible. Hemodynamic monitoring with a Swan-Ganz catheter can help differentiate shock types and guide treatment, though catheters may increase mortality risk due to selection bias.
Cardiogenic shock is defined as a systolic blood pressure under 90 mmHg and cardiac index under 2.2 L/m/m2 with a pulmonary capillary wedge pressure over 18 mmHg, caused by impaired cardiac function and inadequate tissue perfusion. Signs include cool skin, tachypnea, hypotension, and altered mental status. Treatment goals are airway stability and improving myocardial pump function through vasoactive drugs, intra-aortic balloon pumps, and coronary reperfusion if possible. Hemodynamic monitoring with a Swan-Ganz catheter can help differentiate shock types and guide treatment, though catheters may increase mortality risk due to selection bias.
Cardiogenic shock is defined as a systolic blood pressure under 90 mmHg and cardiac index under 2.2 L/m/m2 with a pulmonary capillary wedge pressure over 18 mmHg, caused by impaired cardiac function and inadequate tissue perfusion. Signs include cool skin, tachypnea, hypotension, and altered mental status. Treatment goals are airway stability and improving myocardial pump function through vasoactive drugs, intra-aortic balloon pumps, and coronary reperfusion if possible. Hemodynamic monitoring with a Swan-Ganz catheter can help differentiate shock types and guide treatment, though catheters may increase mortality risk due to selection bias.
myocardial pump function • Cardiac monitor, pulse oximetry • Supplemental oxygen, IV access • Intubation will decrease preload and result in hypotension • Be prepared to give fluid bolus Hemodynamic monitoring Swan-Ganz Catheter
• Utilized to differentiate types of shock and assist in treatment
response.
• Probably overused by physicians. Studies documenting
increased mortality in patients with catheters versus no catheters, although somewhat swayed by selection bias. Swan –Ganz catheter Pharmacologic intervention Vasoactive drugs Intra-Aortic Balloon Intra-aortic ballon pump Pump Coronary reperfusion Shock trial (Danish, begun 2012) Shock trial Agoritm for revascularization in cardiogenic shock (AHA/ACC guidelines) AHA Recomandations Conclusions